LYOPHILIZED PRODUCT MARKET ANALYSIS

Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Feb 2022
Code : CMI4910
Pages :326
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Increasing product launches and approvals are expected to drive the market growth during the forecast period.

Increasing product launches and approvals for lyophilized products are expected to drive the global lyophilized product market growth over forecast period. For instance, in May 2021, Dr. Reddy’s Laboratories Ltd., an Indian multinational pharmaceutical company, announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the U.S. Food and Drug Administration (USFDA) in the U.S. market

Figure 2. Global Lyophilized Product Market Share (%), By Packaging Type, 2021